Compare CVS Health Corp (CVS) vs ProShares UltraPro QQQ ETF (TQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs ProShares UltraPro QQQ ETF — how do they compare? CVS Health Corp trades at $93.83 (market cap $119.58B), while ProShares UltraPro QQQ ETF trades at $74.51. The key difference: CVS Health Corp pays a 2.84% dividend while ProShares UltraPro QQQ ETF pays none, and ProShares UltraPro QQQ ETF is trading nearer its 52-week high, CVS Health Corp nearer its low. Which is the better fit depends on your goals.
| CVS | TQQQ | |
|---|---|---|
Market Cap | $119.58B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $110.60 | $87.22 |
52-Week Low | $65.51 | $37.89 |
Enterprise Value | $181.93B | — |
Dividend Yield | 2.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.67, down slightly by 0.03% today. The stock shows strong fundamental momentum with recent quarterly earnings beats, including Q2 2026 EPS of $2.58 versus $1.87 expected, and raised 2026 guidance. Valuation metrics appear reasonable with a P/E of 24.67 and P/S of 0.29. Technical indicators are mixed with a bullish overall signal but bearish moving averages, with key support at $95 and resistance at $96.
The outlook for CVS is positive, supported by earnings strength and analyst consensus, but risks include margin pressure and rising debt levels. The consensus price target of $115.90 implies significant upside, though investors should monitor execution on guidance and healthcare regulatory changes.
TQQQ trades at $74.96, up 1.59% with a bullish technical signal supported by moving averages. The leveraged ETF shows strong momentum from AI-driven tech sector performance, though oscillators indicate neutral short-term sentiment. Recent institutional buying activity and positive media coverage highlight continued investor interest in Nasdaq-100 exposure through this 3x leveraged vehicle.
The outlook remains positive given robust tech earnings and AI infrastructure spending, but volatility decay and leverage risks require careful position sizing. TQQQ offers amplified Nasdaq-100 returns during bull markets but faces significant downside risk during market corrections, making it suitable for tactical rather than long-term holdings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About ProShares UltraPro QQQ ETF
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →
